Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol
Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_18
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley